Estados financieros detallados de Lucid Diagnostics Inc. (LUCD): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -25.8%, margen operativo -9.3%, margen neto -9.6%.
Al precio actual de $0.84, LUCD presenta beneficios negativos (P/E no significativo) y un ROE del -404.34%. La capitalización bursátil es de $160M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | $500000 | $377000 | $2.4M | $4.3M | $4.7M |
| Coste de Ventas | 0 | 0 | 0 | $585000 | $3.6M | $8.5M | $8.3M | $7.5M |
| Beneficio Bruto | 0 | 0 | 0 | -$85000 | -$3.2M | -$6.0M | -$3.9M | -$2.8M |
| I+D | $715629 | $3.5M | $5.4M | $9.3M | $11.5M | $7.3M | $6.0M | $5.68B |
| Generales y Administrativos | $615428 | $958722 | $2.8M | $18.0M | $39.8M | $35.7M | $36.62B | $41.58B |
| Gastos Operativos | $1.1M | $4.4M | $8.3M | $27.3M | $52.9M | $42.4M | $42.1M | $46.8M |
| Beneficio Operativo | -$1.1M | -$4.4M | -$8.3M | -$27.4M | -$56.2M | -$48.5M | -$46.1M | -$49.6M |
| EBITDA | $562957 | 0 | $482 | -$27.4M | -$54.2M | -$49.8M | -$44.3M | -$57.1M |
| Gastos por Intereses | 0 | 0 | 0 | $659000 | $8000 | $416000 | $26000 | $22000 |
| Beneficio Antes de Impuestos | -$1.1M | -$4.4M | -$8.3M | -$28.1M | -$56.2M | -$52.7M | -$45.5M | -$58.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$1.1M | -$4.4M | -$8.3M | -$28.1M | -$56.2M | -$52.7M | -$45.5M | -$58.0M |
| BPA | $-0.03 | $-0.12 | $-0.22 | $-0.78 | $-1.55 | $-1.26 | $-1.05 | $-0.69 |
| BPA Diluido | $-0.03 | $-0.12 | $-0.22 | $-0.78 | $-1.55 | $-1.26 | $-1.05 | $-0.69 |
| Acciones en Circulación (Diluidas) | $37.0M | $37.0M | $37.0M | $36.1M | $36.2M | $41.8M | $50.5M | $101.9M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $1.2M | $1.5M | $1.3M | $1.5M |
| Beneficio Bruto | -$486000 | -$356000 | -$591000 | $29000 |
| Beneficio Operativo | -$11.8M | -$14.0M | -$12.1M | -$12.8M |
| EBITDA | -$10.2M | -$16.1M | -$13.7M | -$11.5M |
| Beneficio Neto | -$10.4M | -$16.3M | -$13.9M | -$11.7M |
| BPA | $-0.10 | $-0.12 | $-0.17 | $-0.08 |
| BPA Diluido | $-0.10 | $-0.12 | $-0.17 | $-0.08 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $17800 | $156404 | $111000 | $53.7M | $22.5M | $18.9M | $22.4M | $34.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $200000 | $17000 | $45000 | $405000 | $643000 |
| Inventario | 0 | 0 | $834000 | $493000 | $111000 | $278000 | $341000 | $353000 |
| Activos Corrientes | $17800 | $390900 | $1.4M | $57.3M | $24.4M | $22.1M | $25.1M | $37.5M |
| Inmovilizado Material | 0 | 0 | 0 | $971000 | $3.6M | $2.6M | $3.7M | $2.6M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | $3.4M | $1.4M | $736000 | $315000 |
| Activos Totales | $17800 | $1.0M | $2.2M | $59.0M | $32.5M | $27.3M | $30.7M | $40.4M |
| Cuentas por Pagar | $497225 | $799075 | $2.1M | $1.5M | $1.1M | $1.1M | $1.2M | $970000 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $13.9M | $18.6M | $24.0M |
| Pasivos Corrientes | $1.1M | $6.3M | $15.7M | $4.3M | $8.4M | $29.4M | $23.5M | $28.6M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.1M | $6.3M | $15.7M | $4.3M | $9.5M | $29.6M | $25.3M | $29.5M |
| Reservas | -$1.1M | -$5.5M | -$13.8M | -$41.9M | -$98.1M | -$150.7M | -$203.8M | -$274.3M |
| Patrimonio Neto | -$1.1M | -$5.3M | -$13.5M | $54.7M | $23.0M | -$2.3M | $5.4M | $10.9M |
| Deuda Total | 0 | 0 | 0 | 0 | $2.0M | $15.3M | $21.3M | $25.8M |
| Deuda Neta | -$17800 | -$156404 | -$111000 | -$53.7M | -$20.5M | -$3.6M | -$1.1M | -$8.9M |
| Capital Circulante | -$1.1M | -$6.0M | -$14.3M | $53.0M | $15.9M | -$7.3M | $1.6M | $8.9M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $47.3M | $34.70B | $27.9M | $33.4M |
| Activos Totales | $53.2M | $40.4M | $34.1M | $38.9M |
| Pasivos Totales | $27.4M | $29.5M | $30.1M | $28.0M |
| Patrimonio Neto | $25.8M | $10.9M | $4.0M | $10.9M |
| Deuda Total | $24.3M | $25.8M | $26.8M | $24.9M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$1.1M | -$4.4M | -$8.3M | -$28.1M | -$56.2M | -$52.7M | -$45.5M | -$58.0M |
| Amortizaciones | 0 | 0 | 0 | $4000 | $1.9M | $2.5M | $1.2M | $872000 |
| Compensación en Acciones | $79850 | $173945 | $65000 | $9.6M | $15.0M | $6.8M | $4.5M | $4.5M |
| Cambio en Capital Circulante | $720053 | $1.9M | $2.6M | $807000 | $8.9M | $5.7M | -$4.4M | -$2.8M |
| Flujo de Caja Operativo | -$113700 | -$2.4M | -$5.6M | -$17.7M | -$29.7M | -$32.8M | -$44.1M | -$46.5M |
| Inversiones (CapEx) | 0 | -$4 | 0 | -$862000 | -$908000 | -$221000 | -$646000 | -$197000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$113700 | -$2.4M | -$5.6M | -$18.5M | -$30.6M | -$33.0M | -$44.8M | -$46.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$10.9M | -$12.6M | -$12.1M | -$11.3M |
| Inversiones (CapEx) | -$28000 | -$51000 | -$215000 | -$21000 |
| Flujo de Caja Libre | -$10.9M | -$12.6M | -$12.3M | -$11.3M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.2M | $2.29B | $1.4M | $1.7M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | -24.6% | +544.0% | +79.0% | +8.3% |
| Crecimiento Beneficio Neto (anual) | | -292.6% | -87.3% | -239.1% | -100.1% | +6.2% | +13.6% | -27.4% |
| Crecimiento BPA (anual) | | -294.7% | -83.3% | -254.5% | -98.7% | +18.7% | +16.7% | +34.3% |
| Cambio en Acciones (anual) | | +0.0% | +0.0% | -2.5% | +0.3% | +15.4% | +21.0% | +101.8% |
| Crecimiento FCF (anual) | | -1976.9% | -138.4% | -229.2% | -65.1% | -8.0% | -35.6% | -3.8% |
| Margen Bruto | | | | -17.0% | -858.6% | -249.2% | -90.2% | -60.3% |
| Margen Operativo | | | | -5483.8% | -14899.5% | -1996.8% | -1059.6% | -1054.8% |
| Margen EBITDA | | | | -5483.0% | -14383.8% | -2049.1% | -1020.2% | -1213.7% |
| Margen Neto | | | | -5615.6% | -14899.5% | -2169.1% | -1047.6% | -1232.7% |
| Margen FCF | | | | -3706.0% | -8114.9% | -1360.7% | -1030.5% | -987.8% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.00 | $-0.06 | $-0.15 | $-0.51 | $-0.85 | $-0.79 | $-0.89 | $-0.46 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $37.0M | $37.0M | $37.0M | $36.1M | $36.2M | $41.8M | $50.5M | $101.9M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -404.34% |
| Rentabilidad sobre capital invertido | -141.44% |
| Rentabilidad sobre activos | -134.18% |
| Margen bruto | -25.79% |
| Margen operativo | -930.85% |
| Margen neto | -959.76% |
Salud financiera
| Deuda / Patrimonio | 2.28 |
| Ratio corriente | 1.33 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -386.84 | -98.00 | -53.45 | -6.88 | -0.88 | -1.12 | -0.78 | -1.58 |
| P/VC | -409.37 | -81.94 | -32.18 | 3.54 | 2.13 | -25.48 | 7.67 | 10.16 |
| P/V | 0.00 | 0.00 | 0.00 | 387.26 | 130.49 | 24.25 | 9.52 | 23.61 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | -17.0% | -858.6% | -249.2% | -90.2% | -60.3% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | -5483.8% | -14899.5% | -1996.8% | -1059.6% | -1054.8% |
| Margen Neto | 0.0% | 0.0% | 0.0% | -5615.6% | -14899.5% | -2169.1% | -1047.6% | -1232.7% |